系统性硬化症的进展：从发病机制到新型治疗靶点
Advances in Systemic Sclerosis: From Pathogenetic Pathways toward Novel Therapeutic Targets.
作者信息
Romano Eloisa, Rosa Irene, Manetti Mirko
机构信息
Section of Internal Medicine, Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy.
Section of Anatomy and Histology, Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy.
出版信息
Life (Basel). 2023 Feb 13;13(2):513. doi: 10.3390/life13020513.
Abstract
Systemic sclerosis (SSc, or scleroderma) is a multifaceted rare connective tissue disease [...].
摘要
系统性硬化症（SSc，或硬皮病）是一种多方面的罕见结缔组织疾病[...]。
相似文献
1
Advances in Systemic Sclerosis: From Pathogenetic Pathways toward Novel Therapeutic Targets.系统性硬化症的进展：从发病机制到新型治疗靶点
Life (Basel). 2023 Feb 13;13(2):513. doi: 10.3390/life13020513.
2
[Lung impairment in systemic sclerosis].[系统性硬化症中的肺部损害]
Pneumologie. 2009 Sep;63(9):497-507. doi: 10.1055/s-0029-1214908. Epub 2009 Aug 25.
3
Interstitial Lung Disease in Patients With Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD).系统性硬化症患者的间质性肺病：基于个体化医学的系统性硬化症相关间质性肺病（SSc-ILD）预测和药物筛选模型。
Front Immunol. 2020 Sep 4;11:1990. doi: 10.3389/fimmu.2020.01990. eCollection 2020.
4
Undifferentiated Connective Tissue Disease at risk for systemic sclerosis (SSc) (so far referred to as very early/early SSc or pre-SSc).未分化结缔组织病有发生系统性硬化症（SSc）的风险（至今被称为早期/极早期 SSc 或 pre-SSc）。
Autoimmun Rev. 2015 Mar;14(3):210-3. doi: 10.1016/j.autrev.2014.11.002. Epub 2014 Nov 18.
5
Recent advances in understanding the pathogenesis of scleroderma-interstitial lung disease.硬皮病-间质性肺疾病发病机制研究的最新进展
Curr Rheumatol Rep. 2014 Apr;16(4):411. doi: 10.1007/s11926-014-0411-1.
6
Chronic dyspnea with Raynaud's phenomenon and elevated ANA: A diagnosis of systemic sclerosis sine scleroderma.伴有雷诺现象和抗核抗体升高的慢性呼吸困难：无硬皮病的系统性硬化症诊断。
Am J Med Sci. 2023 Feb;365(2):198-204. doi: 10.1016/j.amjms.2022.01.023. Epub 2022 Mar 8.
7
Cardiac involvement in undifferentiated connective tissue disease at risk for systemic sclerosis (otherwise referred to as very early-early systemic sclerosis): a TDI study.未分化结缔组织病心脏受累风险的系统性硬化症（也称为早期极早期系统性硬化症）：一项 TDI 研究。
Clin Exp Med. 2018 May;18(2):237-243. doi: 10.1007/s10238-017-0477-y. Epub 2017 Oct 9.
8
Type I interferon dysregulation in Systemic Sclerosis.Ⅰ型干扰素失调与系统性硬化症。
Cytokine. 2020 Aug;132:154635. doi: 10.1016/j.cyto.2018.12.018. Epub 2019 Jan 23.
9
Therapeutic targets in systemic sclerosis.系统性硬化症的治疗靶点。
Arthritis Res Ther. 2007;9 Suppl 2(Suppl 2):S6. doi: 10.1186/ar2190.
10
Nailfold Capillaroscopy - Its Role in Diagnosis and Differential Diagnosis of Microvascular Damage in Systemic Sclerosis.甲襞毛细血管镜检查——其在系统性硬化症微血管损伤诊断及鉴别诊断中的作用
Curr Rheumatol Rev. 2013;9(4):254-60. doi: 10.2174/157339710904140417125241.
引用本文的文献
1
Biomarkers in Systemic Sclerosis: An Overview.系统性硬化症中的生物标志物：概述
Curr Issues Mol Biol. 2023 Sep 25;45(10):7775-7802. doi: 10.3390/cimb45100490.
本文引用的文献
1
Sympatho-Vagal Dysfunction in Systemic Sclerosis: A Follow-Up Study.系统性硬化症中的交感-迷走神经功能障碍：一项随访研究。
Life (Basel). 2022 Dec 23;13(1):34. doi: 10.3390/life13010034.
2
Potential Role of JAK Inhibitors in the Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease: A Narrative Review from Pathogenesis to Real-Life Data.JAK抑制剂在系统性硬化症相关间质性肺病治疗中的潜在作用：从发病机制到实际临床数据的叙述性综述
Life (Basel). 2022 Dec 14;12(12):2101. doi: 10.3390/life12122101.
3
Total Facial Autologous Fat Grafting for Treating Skin Manifestations in Scleroderma.全脸自体脂肪移植治疗硬皮病的皮肤表现
Life (Basel). 2022 Nov 30;12(12):1997. doi: 10.3390/life12121997.
4
Increased Circulating Soluble Junctional Adhesion Molecules in Systemic Sclerosis: Association with Peripheral Microvascular Impairment.系统性硬化症中循环可溶性连接黏附分子增加：与外周微血管损伤的关联
Life (Basel). 2022 Nov 4;12(11):1790. doi: 10.3390/life12111790.
5
Systemic Sclerosis and Idiopathic Portal Hypertension: Report of a Case and Review of the Literature.系统性硬化症与特发性门静脉高压症：一例报告及文献综述
Life (Basel). 2022 Nov 4;12(11):1781. doi: 10.3390/life12111781.
6
Recent advances in elucidating the genetic basis of systemic sclerosis.阐明系统性硬化症遗传基础的最新进展。
Curr Opin Rheumatol. 2022 Nov 1;34(6):295-301. doi: 10.1097/BOR.0000000000000897. Epub 2022 Aug 16.
7
Circulating Neurovascular Guidance Molecules and Their Relationship with Peripheral Microvascular Impairment in Systemic Sclerosis.循环神经血管导向分子及其与系统性硬化症外周微血管损伤的关系
Life (Basel). 2022 Jul 14;12(7):1056. doi: 10.3390/life12071056.
8
Animal Models of Systemic Sclerosis: Using Nailfold Capillaroscopy as a Potential Tool to Evaluate Microcirculation and Microangiopathy: A Narrative Review.系统性硬化症的动物模型：将甲襞毛细血管镜检查作为评估微循环和微血管病变的潜在工具：一项叙述性综述
Life (Basel). 2022 May 8;12(5):703. doi: 10.3390/life12050703.
9
Genetic Association between TNFA Polymorphisms (rs1799964 and rs361525) and Susceptibility to Cancer in Systemic Sclerosis.肿瘤坏死因子α基因多态性（rs1799964和rs361525）与系统性硬化症癌症易感性之间的遗传关联
Life (Basel). 2022 May 7;12(5):698. doi: 10.3390/life12050698.
10
Serum C-X-C Chemokine Ligand 1 Levels in Patients with Systemic Sclerosis: Relationship of Clinical and Laboratory Observations to Anti-CD20 Monoclonal Antibody Administration.系统性硬化症患者血清C-X-C趋化因子配体1水平：临床及实验室观察结果与抗CD20单克隆抗体给药的关系
Life (Basel). 2022 Apr 27;12(5):646. doi: 10.3390/life12050646.
Zotero 插件